Purple Biotech Ltd.
PPBT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614744
No open-market purchases or sales by Purple Biotech Ltd. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $141.0K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Purple Biotech Ltd. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 21 | 11 | −10 |
| SharesConverted for a 1-for-20 split | 95.4K | 170.4K | +75.0K (+78.6%) |
| Value | $775.9K | $946.1K | +$170.2K (+21.9%) |
New holders (3)
Institutions that held Purple Biotech Ltd. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BNP Paribas Arbitrage, SA | 3,675 | $20.4K | 0.00% |
| Tower Research Capital LLC (TRC) | 254 | $1.42K | 0.00% |
| Danske Bank A/S | 4 | $22 | 0.00% |
Sold out (13)
Institutions that held Purple Biotech Ltd. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Kingswood Wealth Advisors, LLC | 208,060 | $84.7K |
| Citadel Advisors LLC | 24,628 | $10.2K |
| Venture Visionary Partners LLC | 22,161 | $9.02K |
| Virtu Financial LLC | 19,273 | $8.00K |
| Wealth Advisors of Iowa, LLC | 14,270 | $5.81K |
| Geode Capital Management, LLC | 12,666 | $5.26K |
| UBS Group AG | 12,852 | $5.23K |
| HRT Financial LP | 13,739 | $5.00K |
| Raymond James & Associates | 10,000 | $4.07K |
| Sound Income Strategies, LLC | 100 | $41 |
| Aviso Financial Inc. | 51 | $20 |
| Rhumbline Advisers | 16 | $6 |
| Simplex Trading, LLC | 708 | $0 |